| （単位：千ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 |
|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 12,666 | 16,242 | 18,729 | 19,647 | 19,767 | 23,548 | 26,559 | 26,327 | 24,511 |
| 営業費用 | 17,481 | 21,569 | 24,802 | 27,059 | 27,406 | 31,372 | 34,653 | 34,135 | 33,089 |
| 営業利益 | -17,481 | -21,569 | -24,802 | -27,059 | -27,406 | -31,372 | -34,653 | -34,135 | -33,089 |
| 純利益 | -17,457 | -21,445 | -24,702 | -26,902 | -27,069 | -30,737 | -32,940 | -31,918 | -30,733 |
| 一株あたり利益 | -0.4 | -0.49 | -0.57 | -0.61 | -0.62 | -0.7 | -0.73 | -0.68 | -0.65 |
| 希薄化後一株あたり利益 | -0.4 | -0.49 | -0.57 | -0.61 | -0.62 | -0.7 | -0.73 | -0.68 | -0.65 |
| EBITDA | - | - | - | - | - | - |